PMN

ProMIS NeurosciencesF

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-21

View Chart

Current thesis

Composite grade F from latest DB weights. Momentum 15.2 / Value 41.1

Posture

Defensive

Lead driver

Value

What changed

Value remains the lead driver in the composite, 7D delta -15.9.

What can break

Mixed signals. Wait for cleaner trend confirmation.

Momentum

Value

Sentiment

N/A

Setup hits (3d)

0 · Net Neutral

AI TargetsBase - · Bull - · Bear -

Data freshness

Prices

As of 2026-07-21

Fundamentals

As of 2026-07-21 • Vendor: Data Vendor v1

Scores

As of 2026-07-21 • Model: HYBRID_IC_RP

AI Memo

Unavailable: No memo yet

Investment thesis

As of 2026-07-21

Supporting evidence

What

Grade F · Defensive

Confidence Medium · Net Neutral

Target $32.75

Why

Momentum15 · Δ7d -

Value41 · Δ7d -15.9

SentimentN/A · Δ7d -

So what

Weak posture (Net Neutral). Prioritize risk control and patience.

Lead driver: Value · See fundamentals

Momentum

40% active weight

Current posture

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Value

60% active weight

Current posture

7d trendSoftening

Δ7d

-15.9

Δ21d

-16.2

Sentiment

N/A

Coverage pending

No current score

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Why this grade

Composite grade F. Momentum 15.2 / Value 41.1

Fundamentals (TTM)

As of 2026-07-21

Market Cap

$129.94M

Beta

-0.09

Shares Out

8.97M

P/E (TTM) · Derived

-0.6

P/S (TTM)

P/FCF (TTM) · Derived

-1.02

Rev YoY

-100.0%

EPS YoY

-76.0%

Gross Margin

Op Margin

Net Debt

-$6.15M

Current Ratio

9.92

As of 2026-07-21 • Updated nightlySource: Internal modelMethodology